cryptotanshinone has been researched along with ferruginol in 2 studies
| Studies (cryptotanshinone) | Trials (cryptotanshinone) | Recent Studies (post-2010) (cryptotanshinone) | Studies (ferruginol) | Trials (ferruginol) | Recent Studies (post-2010) (ferruginol) |
|---|---|---|---|---|---|
| 370 | 0 | 268 | 65 | 0 | 43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, M; Fronza, M; Hamburger, M; Heinzmann, B; Laufer, S; Merfort, I; Murillo, R; Ślusarczyk, S | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
2 other study(ies) available for cryptotanshinone and ferruginol
| Article | Year |
|---|---|
In vitro cytotoxic activity of abietane diterpenes from Peltodon longipes as well as Salvia miltiorrhiza and Salvia sahendica.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cytotoxins; Drug Screening Assays, Antitumor; Humans; Lamiaceae; Phytotherapy; Plant Extracts; Plant Roots; Salvia; Structure-Activity Relationship | 2011 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |